Skip to main content
. 2016 Mar 30;32(6):497–511. doi: 10.1002/dmrr.2775

Figure 1.

Figure 1

Options for intensification of basal insulin treatment and strategies for the use of glucagon‐like peptide‐1 receptor agonists